Off-Label Use Of Rituximab For Systemic Lupus Erythematosus in Europe: Limited Use Mostly In Refractory Patients
Yazar
Kovacs, Laszlo
Huizinga, T. W. J.
Ruiz-Irastorza, Guillermo
Isenberg, David A.
Castro, A.
van Vollenhoven, Ronald F.
Mild, Melinda
Doria, Andrea
Doerner, T.
Ferraccioli, Gianfranco
Houssiau, Frederic
Inanc, Murat
Jacobsen, Soren
Szuecs, Gabriella
Sebastiani, G. D.
Mosca, Marta
Voskuyl, Alexandre
Squatrito, Danilo
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Bildiri [64839]